Treatment of Multifocal Multisystem BRAF Positive Langerhans Cell Histiocytosis with Cladribine, Surgery and Allogenic Stem Cell Transplantation
2017 ◽
Vol 60
(4)
◽
pp. 152-156
◽
Keyword(s):
Langerhans cell histiocytosis (LCH) is a very rare disease in adults and as well a very rare cause of sellar expansion. The clinical presentation can be heterogeneous, from a single bone lesion to potentially fatal, widespread disease. We describe the difficulties with the diagnosis and treatment of LCH as well as successful treatment with cladribine chemotherapy and allogeneic stem cell transplantation.
2018 ◽
Vol 37
(01)
◽
pp. 76-79
◽
2009 ◽
Vol 4
(2)
◽
pp. 161-167
◽
1999 ◽
Vol 24
(8)
◽
pp. 935-938
◽
2005 ◽
Vol 36
(3)
◽
pp. 215-225
◽
2009 ◽
Vol 13
(3)
◽
pp. 371-374
◽
2015 ◽
Vol 169
(5)
◽
pp. 711-718
◽
2019 ◽
Vol 111
(1)
◽
pp. 137-148
◽
2009 ◽
Vol 45
(5)
◽
pp. 901-906
◽
2020 ◽